Taladro, Rhofine C.

HRN: 24-76-39  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2024
CEFUROXIME 750MG (VIAL)
12/03/2024
12/10/2024
INTRAVENOUS
235 Mg
Every 8 Hours
PCAP-C
Waiting Final Action 
12/08/2024
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
12/08/2024
12/14/2024
PO
2ml
BID
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: